Evodenoson T31731
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Evodenoson( ATL313 and DE-112) is an effective and selective A(2A)AR agonist (A2A adenosine receptor agonist) in development for a novel treatment for sepsis.ATL313 can reduce inflammation and promotes survival in murine sepsis models.
CAS nr:
844873-47-8
Purity:
98%
Molecular Weight:
499,53
SMILES:
O=C(N1CCC(CC#CC2=NC(N)=C3N=CN([C@@H]4O[C@H](C(NC5CC5)=O)[C@@H](O)[C@H]4O)C3=N2)CC1)OC
Formula:
C23H29N7O6
Pathway:
Target:
